Apollo Hospitals Enterprise Reports Second Quarter Financial Results

Market snapshot: Apollo Hospitals Enterprise Limited has reported Q2 revenue of ₹7,615 crore compared to ₹6,200 crore in the prior year period (as stated in the source alert; not independently verified). The earnings release follows scheduled board reviews for the three months ended September 30, 2026.

Data Snapshot

• Apollo Hospitals Enterprise Limited scheduled its board meeting on November 4, 2026, to consider and approve unaudited financial results for Q2 FY27.
• Average Revenue per Inpatient reached ₹1.87 lakh in Q1 FY27, demonstrating an 8% YoY increase.
• Apollo HealthCo registered ₹2,977 crore in revenue alongside EBITDA of ₹171 crore in Q1 FY27.

What's Changed

• Average Revenue per Inpatient increased 8% YoY to ₹1.87 lakh in Q1 FY27.
• Apollo HealthCo generated ₹2,977 crore in Q1 FY27 revenue, building scale across retail pharmacy and digital health networks.

Key Takeaways

• Apollo Hospitals is advancing bed capacity with recent unit additions in key metro markets.
• Inpatient yield growth continues to underpin core healthcare services operational performance.
• Digital health and pharmacy business integration via Apollo HealthCo is contributing meaningful revenue scale.

SAHI Perspective

The combination of higher per-inpatient revenue metrics and ongoing bed expansions provides sustained structural tailwinds for Apollo Hospitals. Continued operational execution across healthcare services and digital pharmacy streams underpins medium-term revenue stability.

Market Implications

Steady realization improvements and network expansions reinforce hospital cluster economics. Investors will monitor detailed EBITDA margin splits across hospital networks and digital health operations during upcoming management calls.

Trading Signals

Market Bias: Bullish

Continued underlying growth in inpatient realization (up 8% YoY to ₹1.87 lakh) and hospital capacity expansion maintain positive operational momentum.

Overweight: Healthcare Services, Hospitals

Trigger Factors:

• Official BSE detailed segment result upload for Q2 FY27
• Occupancy rate trends across newly commissioned hospital beds
• Apollo 24/7 digital health division margin commentary

Time Horizon: Near-term (0-3 months)

Industry Context

India's tertiary healthcare providers continue to benefit from structural demand drivers, including expanding medical insurance coverage, growing surgical complexity, and tariff optimization across major hospital chains.

Key Risks to Watch

• Occupancy fluctuations during seasonal transitions
• Gestational losses associated with rapid commissioning of new hospital beds
• Regulatory adjustments on medical procedure tariffs or pharmaceutical margins

Recent Developments

Apollo Hospitals scheduled its Q2 FY27 earnings call for November 5, 2026, and recently commissioned a 180-bed facility in Sarjapur, Bangalore.

Closing Insight

Monetization of expanded bed capacity and realization growth remain central drivers for long-term equity valuation in premier healthcare networks.

High Performance Trading with SAHI.